阿联酋迪拜一家三级医院重症监护室的临床药剂师干预降低了重症监护室的死亡率

IF 1.8 Q3 PHARMACOLOGY & PHARMACY Exploratory research in clinical and social pharmacy Pub Date : 2024-03-09 DOI:10.1016/j.rcsop.2024.100431
Hawra Ali Hussain Alsayed , Fatemeh Saheb Sharif-Askari , Narjes Saheb Sharif-Askari , Rabih Halwani
{"title":"阿联酋迪拜一家三级医院重症监护室的临床药剂师干预降低了重症监护室的死亡率","authors":"Hawra Ali Hussain Alsayed ,&nbsp;Fatemeh Saheb Sharif-Askari ,&nbsp;Narjes Saheb Sharif-Askari ,&nbsp;Rabih Halwani","doi":"10.1016/j.rcsop.2024.100431","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Drug-related problems (DRPs) are prevalent in critical care settings and can be life-threatening. Involving clinical pharmacists (CP) within the critical care team is recommended to optimize therapy and improve patient survival.</p></div><div><h3>Objective</h3><p>To classify DRPs identified by a CP in the Intensive Care Unit (ICU) and to assess the impact of CP interventions accepted by physicians on the length of ICU stay and in-hospital survival.</p></div><div><h3>Methods</h3><p>This study was conducted prospectively at the Medical ICU of Rashid Hospital, a tertiary hospital in Dubai, over a 16-month period from September 2021 to December 2022. The study included patients admitted to ICU during the study period. CP interventions were documented, and DRPs were classified using the modified Pharmaceutical Care Network Europe V.9.1.</p></div><div><h3>Results</h3><p>During the study period, 1004 interventions were recommended for 200 patients. The majority of these interventions, 92% (<em>n</em> = 922), received physician acceptance, and 82% (<em>n</em> = 820) were fully implemented by the physician. In total, 1033 drug-related problems (DRPs) were identified, with a median of 3 DRPs per patient. The most common DRPs was drug selection (61%), followed by dose selection (22%). There were 337 DRPs related to antimicrobial agents. Interestingly, we noted that when we adjusted for patients' demographic data and the Glasgow Coma Scale severity score, patients who received &gt;4 implemented interventions exhibited lower cumulative hazard of death within 90 days of their ICU stay in comparison to their counterparts (adjusted Hazard Ratio: 0.10, 95% CI of 0.02–0.41; <em>P</em> = 0.027).</p></div><div><h3>Conclusion</h3><p>The study emphasizes the critical role of CP in the ICU, addressing DRPs, and enhancing overall patient care. Furthermore, it highlights the potential impact of pharmacist interventions in improving patient survival outcomes. This underscores the importance of implementing CP services in ICUs across the UAE.</p></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2024-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266727662400026X/pdfft?md5=eee2e04e3d617c55dc1586b855314d1a&pid=1-s2.0-S266727662400026X-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Clinical pharmacist interventions in an intensive care unit reduces ICU mortality at a tertiary hospital in Dubai, United Arab Emirates\",\"authors\":\"Hawra Ali Hussain Alsayed ,&nbsp;Fatemeh Saheb Sharif-Askari ,&nbsp;Narjes Saheb Sharif-Askari ,&nbsp;Rabih Halwani\",\"doi\":\"10.1016/j.rcsop.2024.100431\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Drug-related problems (DRPs) are prevalent in critical care settings and can be life-threatening. Involving clinical pharmacists (CP) within the critical care team is recommended to optimize therapy and improve patient survival.</p></div><div><h3>Objective</h3><p>To classify DRPs identified by a CP in the Intensive Care Unit (ICU) and to assess the impact of CP interventions accepted by physicians on the length of ICU stay and in-hospital survival.</p></div><div><h3>Methods</h3><p>This study was conducted prospectively at the Medical ICU of Rashid Hospital, a tertiary hospital in Dubai, over a 16-month period from September 2021 to December 2022. The study included patients admitted to ICU during the study period. CP interventions were documented, and DRPs were classified using the modified Pharmaceutical Care Network Europe V.9.1.</p></div><div><h3>Results</h3><p>During the study period, 1004 interventions were recommended for 200 patients. The majority of these interventions, 92% (<em>n</em> = 922), received physician acceptance, and 82% (<em>n</em> = 820) were fully implemented by the physician. In total, 1033 drug-related problems (DRPs) were identified, with a median of 3 DRPs per patient. The most common DRPs was drug selection (61%), followed by dose selection (22%). There were 337 DRPs related to antimicrobial agents. Interestingly, we noted that when we adjusted for patients' demographic data and the Glasgow Coma Scale severity score, patients who received &gt;4 implemented interventions exhibited lower cumulative hazard of death within 90 days of their ICU stay in comparison to their counterparts (adjusted Hazard Ratio: 0.10, 95% CI of 0.02–0.41; <em>P</em> = 0.027).</p></div><div><h3>Conclusion</h3><p>The study emphasizes the critical role of CP in the ICU, addressing DRPs, and enhancing overall patient care. Furthermore, it highlights the potential impact of pharmacist interventions in improving patient survival outcomes. This underscores the importance of implementing CP services in ICUs across the UAE.</p></div>\",\"PeriodicalId\":73003,\"journal\":{\"name\":\"Exploratory research in clinical and social pharmacy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2024-03-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S266727662400026X/pdfft?md5=eee2e04e3d617c55dc1586b855314d1a&pid=1-s2.0-S266727662400026X-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Exploratory research in clinical and social pharmacy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S266727662400026X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Exploratory research in clinical and social pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S266727662400026X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

背景药物相关问题(DRPs)在重症监护环境中十分普遍,并可能危及生命。目标对重症监护病房(ICU)中由临床药师识别的 DRP 进行分类,并评估医生接受的临床药师干预措施对 ICU 住院时间和院内存活率的影响。方法本研究于 2021 年 9 月至 2022 年 12 月的 16 个月期间在迪拜的一家三甲医院拉希德医院的内科 ICU 进行了前瞻性研究。研究对象包括研究期间入住重症监护室的患者。结果在研究期间,为 200 名患者推荐了 1004 次干预。其中,92%(n = 922)的干预措施得到了医生的认可,82%(n = 820)的干预措施得到了医生的全面实施。总共发现了 1033 个与药物相关的问题 (DRP),每个患者的 DRP 中位数为 3 个。最常见的 DRP 是药物选择(61%),其次是剂量选择(22%)。有 337 个 DRP 与抗菌药物有关。有趣的是,我们注意到,当我们对患者的人口统计学数据和格拉斯哥昏迷量表严重程度评分进行调整后,接受了>4项干预措施的患者在入住重症监护室后90天内的累积死亡风险低于同类患者(调整后危险比:0.10,95% CI为0.02-0.41;P = 0.027)。此外,研究还强调了药剂师干预对改善患者生存结果的潜在影响。这凸显了在阿联酋各地的重症监护室中实施 CP 服务的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Clinical pharmacist interventions in an intensive care unit reduces ICU mortality at a tertiary hospital in Dubai, United Arab Emirates

Background

Drug-related problems (DRPs) are prevalent in critical care settings and can be life-threatening. Involving clinical pharmacists (CP) within the critical care team is recommended to optimize therapy and improve patient survival.

Objective

To classify DRPs identified by a CP in the Intensive Care Unit (ICU) and to assess the impact of CP interventions accepted by physicians on the length of ICU stay and in-hospital survival.

Methods

This study was conducted prospectively at the Medical ICU of Rashid Hospital, a tertiary hospital in Dubai, over a 16-month period from September 2021 to December 2022. The study included patients admitted to ICU during the study period. CP interventions were documented, and DRPs were classified using the modified Pharmaceutical Care Network Europe V.9.1.

Results

During the study period, 1004 interventions were recommended for 200 patients. The majority of these interventions, 92% (n = 922), received physician acceptance, and 82% (n = 820) were fully implemented by the physician. In total, 1033 drug-related problems (DRPs) were identified, with a median of 3 DRPs per patient. The most common DRPs was drug selection (61%), followed by dose selection (22%). There were 337 DRPs related to antimicrobial agents. Interestingly, we noted that when we adjusted for patients' demographic data and the Glasgow Coma Scale severity score, patients who received >4 implemented interventions exhibited lower cumulative hazard of death within 90 days of their ICU stay in comparison to their counterparts (adjusted Hazard Ratio: 0.10, 95% CI of 0.02–0.41; P = 0.027).

Conclusion

The study emphasizes the critical role of CP in the ICU, addressing DRPs, and enhancing overall patient care. Furthermore, it highlights the potential impact of pharmacist interventions in improving patient survival outcomes. This underscores the importance of implementing CP services in ICUs across the UAE.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.60
自引率
0.00%
发文量
0
审稿时长
103 days
期刊最新文献
Montelukast deprescribing in outpatient specialty clinics: A single center cross-sectional study Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation at a tertiary care hospital in Thailand Comparing nursing medication rounds before and after implementation of automated dispensing cabinets: A time and motion study Translation, transcultural adaptation, and validation of the Brazilian Portuguese version of the general medication adherence scale (GMAS) in patients with high blood pressure A cross-sectional survey exploring organizational readiness to implement community pharmacy-based opioid counseling and naloxone services in rural versus urban settings in Alabama
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1